The European Medicines Agency (EMA) said on Tuesday it hoped to rule as early as July on the possibility of using Moderna’s coronavirus vaccine for young people aged 12 to 17.
Following the request for conditional authorization filed Monday by the American biotechnology company, the agency indicated that it would proceed to a “accelerated assessment». «EMA will communicate the result of its assessment, which is expected to take place in July, unless further information is required», She clarified. The agency said the Moderna vaccine, which has been approved for adults in the EU since January, will be reviewed based on the results of a large clinical trial in adolescents. The regulator approved the first vaccine for European adolescents, manufactured by Pfizer / BioNTech, in May.
SEE ALSO – “Now I can go out without fear”: Israel opens its vaccination campaign against the Covid-19 to adolescents aged 12-16